SANTAMATO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 3.975
NA - Nord America 3.320
AS - Asia 1.533
AF - Africa 50
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 14
Totale 8.935
Nazione #
US - Stati Uniti d'America 3.296
IE - Irlanda 1.405
CN - Cina 968
UA - Ucraina 822
SE - Svezia 484
FR - Francia 421
IT - Italia 274
IN - India 196
TR - Turchia 171
FI - Finlandia 128
GB - Regno Unito 122
DE - Germania 116
BE - Belgio 83
PK - Pakistan 47
EG - Egitto 35
JP - Giappone 34
PL - Polonia 30
IR - Iran 24
CA - Canada 20
AU - Australia 19
NL - Olanda 18
EU - Europa 17
SG - Singapore 15
TH - Thailandia 14
HK - Hong Kong 13
ES - Italia 12
MY - Malesia 12
RU - Federazione Russa 11
LY - Libia 9
RO - Romania 9
CZ - Repubblica Ceca 8
GR - Grecia 8
ID - Indonesia 7
TW - Taiwan 6
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
SI - Slovenia 5
CH - Svizzera 4
CO - Colombia 4
MX - Messico 4
BD - Bangladesh 3
BR - Brasile 3
CL - Cile 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SM - San Marino 2
TN - Tunisia 2
YE - Yemen 2
AR - Argentina 1
AT - Austria 1
EC - Ecuador 1
KR - Corea 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
SY - Repubblica araba siriana 1
VN - Vietnam 1
Totale 8.935
Città #
Dublin 1.404
Jacksonville 579
Dearborn 430
Chandler 391
Nyköping 339
Nanjing 275
Wilmington 168
Beijing 142
Ashburn 140
Princeton 135
Nanchang 119
New York 118
San Mateo 94
Ann Arbor 82
Brussels 79
Shenyang 56
Hebei 44
Kunming 42
Tianjin 42
Des Moines 41
Helsinki 37
Seattle 36
Boardman 34
Woodbridge 33
Jinan 29
Jiaxing 28
Changsha 27
Ningbo 26
Hangzhou 25
Foggia 24
Pune 24
Bari 20
Zhengzhou 20
Guangzhou 17
Hilden 17
Philadelphia 17
Los Angeles 15
Kraków 13
Lanzhou 13
Flushing 12
Houston 12
London 12
Redwood City 12
Changchun 11
Ismailia 11
Kocaeli 11
Lahore 11
Rome 11
San Francisco 11
Bengaluru 10
Berlin 10
Milan 10
Paris 10
San Genesio Ed Uniti 10
Bangkok 9
Giza 9
Hanover 9
Istanbul 9
Taizhou 9
Tripoli 9
Faisalabad 8
Athens 7
Dallas 7
Lethbridge 7
Norwalk 7
Shanghai 7
Ankara 6
Auburn Hills 6
Fuzhou 6
Hefei 6
Independence 6
Islamabad 6
Saint Petersburg 6
Taipei 6
Al Mansurah 5
Chicago 5
Delhi 5
Duncan 5
Düsseldorf 5
Las Vegas 5
Mountain View 5
New Orleans 5
Oulu 5
Singapore 5
Verona 5
Warsaw 5
Washington 5
Ahmedabad 4
Birmingham 4
Bloomington 4
Chennai 4
Florence 4
Frankfurt am Main 4
Gdansk 4
Hyderabad 4
Jakarta 4
Jeddah 4
Kuala Lumpur 4
Naples 4
Nishigaoka 4
Totale 5.601
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 432
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 157
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 153
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 125
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 117
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 116
Lifestyle-related factors in predementia and dementia syndromes. 112
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 112
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 111
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 108
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 106
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 106
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 105
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 101
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 101
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 100
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 99
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 99
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 94
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 93
Current and emerging treatments for amyotrophic lateral sclerosis. 90
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 90
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 88
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 88
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 87
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 87
Lipoproteins, vascular-related genetic factors, and human longevity. 85
Vascular risk factors, alcohol intake, and cognitive decline 84
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 84
Progression to dementia in probable and possible mild cognitive impairment 83
L'ESERCIZIO ISOCINETICO 83
Lifestyle-related factors in predementia and dementia syndromes. 83
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 81
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 80
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 80
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 79
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 79
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 78
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 78
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 77
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 77
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 77
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 76
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 75
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 74
Higher total cholesterol, cognitive decline, and dementia. 73
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 73
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 72
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 71
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 71
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 70
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 70
Hypertension and mild cognitive impairment subtypes 69
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 69
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 69
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 68
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 68
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 67
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 66
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 66
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 66
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 65
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 65
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 64
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 64
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 63
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 63
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 62
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 62
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 62
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 62
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 61
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 61
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches 61
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 61
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 60
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 60
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 60
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 60
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 59
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 59
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 59
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 58
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 57
Current epidemiological approaches to the metabolic-cognitive syndrome. 56
Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies. 56
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 56
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 56
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 55
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 55
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 55
Post-stroke spasticity as a condition: a new perspective on patient evaluation 55
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 55
Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors. 54
Pulmonary rehabilitation for patients with bronchiectasis: case reports. 53
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 53
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 53
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 53
Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: A case series summary and review of the literature 52
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 52
Totale 7.975
Categoria #
all - tutte 39.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019212 0 0 0 0 0 0 0 12 9 13 44 134
2019/20202.004 420 199 142 41 249 278 267 31 149 37 173 18
2020/20211.182 160 6 129 6 175 63 166 151 167 145 2 12
2021/2022682 100 5 32 32 39 6 17 55 99 57 46 194
2022/20233.312 245 100 88 121 104 205 95 308 1.616 105 172 153
2023/2024529 57 33 27 29 84 238 20 41 0 0 0 0
Totale 9.330